Skip to main content
Account

Table 2 Results of blood examination results from the retro-orbital sinus of mice after the administration of liposome formulations

From: Preparation and Evaluation of Liposomes Co-Loaded with Doxorubicin, Phospholipase D Inhibitor 5-Fluoro-2-Indolyl Deschlorohalopemide (FIPI) and D-Alpha Tocopheryl Acid Succinate (α-TOS) for Anti-Metastasis

Assay

Control

Blank-lip

DFT-lip

GR

1.25 ± 0.44

1.27 ± 0.51

1.09 ± 0.64

GR%

17.20 ± 5.44

17.29 ± 5.97

18.85 ± 12.29

HCT

49.04 ± 1.01

48.96 ± 2.24

48.41 ± 1.68

HGB

163.25 ± 4.27

160.00 ± 4.87

156.25 ± 5.34

LY

5.11 ± 0.96

4.43 ± 0.97

4.04 ± 1.07

LY%

69.81 ± 7.25

63.34 ± 8.49

63.99 ± 10.53

MCH

16.28 ± 0.38

16.28 ± 0.34

15.84 ± 0.35

MCHC

333.00 ± 9.21

327.13 ± 8.85

322.63 ± 6.21

MCV

48.85 ± 1.11

49.76 ± 1.26

49.10 ± 1.22

MO

0.94 ± 0.40

1.34 ± 0.43

1.09 ± 0.34

MO%

12.99 ± 5.56

19.37 ± 5.54

17.16 ± 3.74

MPV

5.31 ± 0.15

5.45 ± 0.21

5.51 ± 0.17

PCT

0.24 ± 0.03

0.26 ± 0.02

0.23 ± 0.03

PDW

13.61 ± 0.79

13.94 ± 0.96

13.74 ± 0.39

PLT

451.25 ± 47.78

481.75 ± 32.47

419.38 ± 44.64

RBC

10.04 ± 0.26

9.83 ± 0.42

9.85 ± 0.21

RDW

14.25 ± 0.97

14.19 ± 0.66

14.73 ± 1.07

WBC

7.30 ± 1.22

7.04 ± 1.29

6.21 ± 0.96

  1. Data are presented as the mean ± SD (n = 8). GR, neutrophil granulocyte; HCT, hematocrit; HGB, hemoglobin; LY, lymphocyte; MCH, mean corpuscular hemoglobin; MCHC, mean corpuscular hemoglobin concentration; MCV, mean corpuscular volume; MO, intermediate cell; MPV, mean platelet volume; PCT, thrombocytocrit; PDW, platelet distribution width; PLT, platelet; RBC, red blood cells; RDW, red cell volume distribution width; WBC, white blood cells

Navigation